Nordic Bioscience and Roche Diagnostics Strengthen Collaboration for Development of Biomarkers for Chronic Diseases
We showcase how the Nordic Bioscience Protein Fingerprint neo-epitope technology provides serological quantification for Extracellular Matrix (ECM) remodeling.
Promising outlook for prognostic biomarkers related to HFpEF
KKR's investment will support Nordic Bioscience with its ambitious growth goals: Global expansion of R&D services, diagnostics platform, leading patent portfolio, and drug development.
No event found
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.